<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:2fca81be-7dff-4548-bc94-c717bfbb6a5c,g:efd972c0-a4d1-4b41-9cc3-073144b90aa6,d:0bdcbaa1c6dc4084879c8ea3ed4dd32f--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>endp-20220502</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl80L2ZyYWc6MjVkNDViYjYxMzgxNGRkOThhYTg4ZGMwYmMwYTU3ZTcvdGV4dHJlZ2lvbjoyNWQ0NWJiNjEzODE0ZGQ5OGFhODhkYzBiYzBhNTdlN182MQ_e3cdd7ef-2dc0-4599-81c3-15683d1c6ee2">0001593034</ix:nonNumeric><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl80L2ZyYWc6MjVkNDViYjYxMzgxNGRkOThhYTg4ZGMwYmMwYTU3ZTcvdGV4dHJlZ2lvbjoyNWQ0NWJiNjEzODE0ZGQ5OGFhODhkYzBiYzBhNTdlN182Mg_e01ace2a-5f28-416b-8f3a-513f6e7292c2">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="endp-20220502.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001593034</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-02</xbrli:startDate><xbrli:endDate>2022-05-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i0bdcbaa1c6dc4084879c8ea3ed4dd32f_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">_______________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18zNjY4_f1bdeadd-8c1e-4326-8776-fbbbb922c109">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">_______________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18yODY_4b74dd29-76b5-4ba3-8b96-cebc6028f9a8">May 2, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_______________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18zNjY5_78c8df1c-c109-42cb-8440-cbe58037f609">Endo International plc</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6YzM5N2IzNmUxMzNlNGNiNDk5NjhhNzFjNTIzYWJhZGUvdGFibGVyYW5nZTpjMzk3YjM2ZTEzM2U0Y2I0OTk2OGE3MWM1MjNhYmFkZV8wLTAtMS0xLTEzOTY4NQ_39b941c2-a540-4de9-9bcf-08e6e06136a5">Ireland</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6YzM5N2IzNmUxMzNlNGNiNDk5NjhhNzFjNTIzYWJhZGUvdGFibGVyYW5nZTpjMzk3YjM2ZTEzM2U0Y2I0OTk2OGE3MWM1MjNhYmFkZV8wLTEtMS0xLTEzOTY4NQ_7d1d731a-8e03-4d5a-9f3f-1d3646f57d53">001-36326</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6YzM5N2IzNmUxMzNlNGNiNDk5NjhhNzFjNTIzYWJhZGUvdGFibGVyYW5nZTpjMzk3YjM2ZTEzM2U0Y2I0OTk2OGE3MWM1MjNhYmFkZV8wLTItMS0xLTEzOTY4NQ_c5000193-e956-460b-96f6-1364ae3aea38">68-0683755</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(IRS Employer</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.292%"><tr><td style="width:1.0%"></td><td style="width:28.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6MWI5OTBmYjU2MTgwNGU3MDgxMmViYzFhNmI2ZWI5NjYvdGFibGVyYW5nZToxYjk5MGZiNTYxODA0ZTcwODEyZWJjMWE2YjZlYjk2Nl8wLTAtMS0xLTEzOTY4NQ_cff4a7fa-908e-481e-8d50-e60f1dab62fb">First Floor, Minerva House, Simmonscourt Road</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2.25pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6MWI5OTBmYjU2MTgwNGU3MDgxMmViYzFhNmI2ZWI5NjYvdGFibGVyYW5nZToxYjk5MGZiNTYxODA0ZTcwODEyZWJjMWE2YjZlYjk2Nl8xLTAtMS0xLTEzOTY4NQ_239f0544-8b7b-4134-ae2b-ad4580fb2546">Ballsbridge, Dublin 4,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6MWI5OTBmYjU2MTgwNGU3MDgxMmViYzFhNmI2ZWI5NjYvdGFibGVyYW5nZToxYjk5MGZiNTYxODA0ZTcwODEyZWJjMWE2YjZlYjk2Nl8xLTEtMS0xLTEzOTY4NQ_0c56810f-a7a8-4a92-b927-2855666e4446">Ireland</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6MWI5OTBmYjU2MTgwNGU3MDgxMmViYzFhNmI2ZWI5NjYvdGFibGVyYW5nZToxYjk5MGZiNTYxODA0ZTcwODEyZWJjMWE2YjZlYjk2Nl8xLTItMS0xLTEzOTY4NQ_d424574b-8758-494e-b485-de719f5a5d02">Not Applicable</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Zip Code)</span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant's telephone number, including area code 011-<ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18zNjcz_1e74a2c3-702e-4537-9770-4eb05868465f">353</ix:nonNumeric>-<ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18zNjcw_555b33f2-5379-4b97-9086-7fa0e7adacb8">1-268-2000</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:144%">(Former name or former address, if changed since last report.)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18zNjcx_5a77eb81-42bb-447f-a9dc-a618bd4ef843">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18zNjc0_5a99c704-7756-4159-9b91-250ce285c443">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18zNjc1_5818a2c2-2f16-46b9-9d82-bacc9ecdf521">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18zNjcy_08f2ff44-6d3c-4233-a34d-dd5bd5792492">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6ZDUwM2UzMmFhODVlNDE1MDk0Zjc1ZTNkMWNmZDYwYTUvdGFibGVyYW5nZTpkNTAzZTMyYWE4NWU0MTUwOTRmNzVlM2QxY2ZkNjBhNV8xLTAtMS0xLTEzOTY4NQ_a0e8a2aa-5e85-4724-b797-0dbb9a4edc56">Ordinary shares, nominal value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6ZDUwM2UzMmFhODVlNDE1MDk0Zjc1ZTNkMWNmZDYwYTUvdGFibGVyYW5nZTpkNTAzZTMyYWE4NWU0MTUwOTRmNzVlM2QxY2ZkNjBhNV8xLTEtMS0xLTEzOTY4NQ_56d1c07f-7125-4830-99d7-b9872bebc33f">ENDP</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGFibGU6ZDUwM2UzMmFhODVlNDE1MDk0Zjc1ZTNkMWNmZDYwYTUvdGFibGVyYW5nZTpkNTAzZTMyYWE4NWU0MTUwOTRmNzVlM2QxY2ZkNjBhNV8xLTItMS0xLTEzOTY4NQ_ee9e395a-4744-4336-8b0a-4293cb830a37">The NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="i4a3822122df647a5b30e2c58bb2f5b57_D20220502-20220502" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjBiZGNiYWExYzZkYzQwODQ4NzljOGVhM2VkNGRkMzJmL3NlYzowYmRjYmFhMWM2ZGM0MDg0ODc5YzhlYTNlZDRkZDMyZl8xL2ZyYWc6ZTg5NzAwODdjZGNkNGE2OWJmMTc0ZTRjYWFjZGZkMjcvdGV4dHJlZ2lvbjplODk3MDA4N2NkY2Q0YTY5YmYxNzRlNGNhYWNkZmQyN18zNjc2_b6393f79-f7f2-444d-9ee9-6fb84eede1ec">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Emerging growth company</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01.&#160;&#160;&#160;&#160;Other Events.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2022, Endo International plc, a public limited company incorporated in Ireland (&#8220;Endo&#8221;), issued a press release announcing the acquisition by one of its subsidiaries of six development-stage ready-to-use injectable product candidates from Nevakar Injectables, Inc., a subsidiary of Nevakar, Inc., for an upfront cash payment of $35&#160;million. A copy of the press release issued by Endo is attached as Exhibit 99.1 hereto and is incorporated herein by reference.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Endo expects to recognize a corresponding acquired in-process research and development charge of $35 million during the second quarter of 2022 in its consolidated statements of operations prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). Additionally, as previously disclosed, beginning with its first-quarter 2022 financial reporting, Endo will no longer exclude acquired in-process research and development charges from the non-GAAP performance measures utilized in connection with its quarterly financial reporting and, as a result, this charge is also expected to affect Endo&#8217;s non-GAAP performance measures.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information in this Current Report on Form 8-K may be considered &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995 and any applicable Canadian securities legislation, including with respect to the financial statement effects of the transaction described herein. Statements including words or phrases such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;look forward,&#8221; &#8220;intend,&#8221; &#8220;guidance,&#8221; &#8220;future,&#8221; &#8220;potential&#8221; or similar expressions are forward-looking statements. Because forecasts are inherently estimates that cannot be made with precision, Endo&#8217;s performance at times differs materially from its estimates and targets, and Endo often does not know what the actual results will be until after the end of the applicable reporting period. Therefore, Endo will not report or comment on its progress during a current quarter except through public announcement. Any statement made by others with respect to progress during a current quarter cannot be attributed to Endo. All forward-looking statements in this Current Report on Form 8-K reflect Endo&#8217;s current analysis of existing trends and information and represent Endo&#8217;s judgment only as of the date of this Current Report on Form 8-K. Actual results may differ materially and adversely from current expectations based on a number of factors affecting Endo&#8217;s businesses. Therefore, the reader is cautioned not to rely on these forward-looking statements. Endo expressly disclaims any intent or obligation to update these forward-looking statements, except as required to do so by law.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01. Financial Statements and Exhibits. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220502ex991nevakarpress.htm">Press Release</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</span></div><div style="margin-top:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.175%"><tr><td style="width:1.0%"></td><td style="width:17.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.778%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ENDO INTERNATIONAL PLC</span></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Matthew J. Maletta</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew J. Maletta</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President,<br/>Chief Legal Officer and Company Secretary</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: May 2, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "endp-20220502.htm", "description": "8-K", "secsgml_size_bytes": 35318}]
{"company-data": {"conformed-name": "Endo International plc", "cik": "0001593034", "assigned-sic": "2834", "irs-number": "680683755", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36326", "film-number": "22879517"}, "business-address": {"street1": "MINERVA HOUSE, SIMMONSCOURT ROAD", "street2": "BALLSBRIDGE", "city": "DUBLIN 4", "state": "L2", "zip": "00000", "phone": "353-1-268-2000"}, "mail-address": {"street1": "MINERVA HOUSE, SIMMONSCOURT ROAD", "street2": "BALLSBRIDGE", "city": "DUBLIN 4", "state": "L2", "zip": "00000"}, "former-company": [{"former-conformed-name": "Endo International Ltd", "date-changed": "20131203"}, {"former-conformed-name": "Sportwell Ltd", "date-changed": "20131126"}]}
endp-20220502
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________________
FORM
8-K
_______________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
May 2, 2022
_______________________________
Endo International plc
(Exact name of registrant as specified in its charter)
_______________________________
Ireland
001-36326
68-0683755
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
First Floor, Minerva House, Simmonscourt Road
Ballsbridge, Dublin 4,
Ireland
Not Applicable
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code 011-
353
-
1-268-2000
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Ordinary shares, nominal value $0.0001 per share
ENDP
The NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01.    Other Events.
On May 2, 2022, Endo International plc, a public limited company incorporated in Ireland ("Endo"), issued a press release announcing the acquisition by one of its subsidiaries of six development-stage ready-to-use injectable product candidates from Nevakar Injectables, Inc., a subsidiary of Nevakar, Inc., for an upfront cash payment of $35 million. A copy of the press release issued by Endo is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
Endo expects to recognize a corresponding acquired in-process research and development charge of $35 million during the second quarter of 2022 in its consolidated statements of operations prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Additionally, as previously disclosed, beginning with its first-quarter 2022 financial reporting, Endo will no longer exclude acquired in-process research and development charges from the non-GAAP performance measures utilized in connection with its quarterly financial reporting and, as a result, this charge is also expected to affect Endo's non-GAAP performance measures.
Cautionary Note Regarding Forward-Looking Statements
Certain information in this Current Report on Form 8-K may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and any applicable Canadian securities legislation, including with respect to the financial statement effects of the transaction described herein. Statements including words or phrases such as "believe," "expect," "anticipate," "intend," "estimate," "plan," "will," "may," "look forward," "intend," "guidance," "future," "potential" or similar expressions are forward-looking statements. Because forecasts are inherently estimates that cannot be made with precision, Endo's performance at times differs materially from its estimates and targets, and Endo often does not know what the actual results will be until after the end of the applicable reporting period. Therefore, Endo will not report or comment on its progress during a current quarter except through public announcement. Any statement made by others with respect to progress during a current quarter cannot be attributed to Endo. All forward-looking statements in this Current Report on Form 8-K reflect Endo's current analysis of existing trends and information and represent Endo's judgment only as of the date of this Current Report on Form 8-K. Actual results may differ materially and adversely from current expectations based on a number of factors affecting Endo's businesses. Therefore, the reader is cautioned not to rely on these forward-looking statements. Endo expressly disclaims any intent or obligation to update these forward-looking statements, except as required to do so by law.
Item 9.01. Financial Statements and Exhibits.
(d)    Exhibits.
Number
Description
99.1
Press Release
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
ENDO INTERNATIONAL PLC
By:
/s/ Matthew J. Maletta
Name:
Matthew J. Maletta
Title:
Executive Vice President,
Chief Legal Officer and Company Secretary
Dated: May 2, 2022